ORTHOPEDIATRICS CORP Cash Flow Statement
KIDS|9 years of annual SEC 10-K data (FY2017-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 9 fiscal years. All figures from audited SEC 10-K filings.
ORTHOPEDIATRICS CORP used $27M in operating cash flow and negative free cash flow of $44M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$21.0M | $1.3M | -$16.3M | -$32.9M | -$13.7M | -$12.0M | -$8.9M | -$6.6M | -$7.9M |
| Depreciation & Amortization | $17.4M | $13.1M | $10.7M | $8.0M | $4.7M | $2.9M | $2.4M | $1.9M | $1.9M |
| Operating Cash Flow | -$27.0M | -$21.8M | -$13.1M | -$18.5M | -$17.8M | -$15.6M | -$7.2M | -$1.1M | -$892.0K |
| Capital Expenditures | $16.9M | $10.0M | $8.1M | $10.5M | $11.8M | $5.3M | $5.2M | $4.3M | $2.2M |
| Free Cash Flow | -$43.9M | -$31.8M | -$21.2M | -$29.0M | -$29.6M | -$20.8M | -$12.4M | -$5.5M | -$3.1M |
| Dividends Paid | - | - | - | - | - | - | $6.0M | $0 | $0 |
| FCF Margin | -29.5% | -26.0% | -21.6% | -40.8% | -40.8% | -36.2% | -27.2% | -14.7% | -10.0% |